Concepedia

Haritha Chiramana

HC

Statistics

Publications

1

Citations

59

H-Index

1

Active since

2011

Affiliations

University of East Anglia(Current)

Haritha Chiramana is an author at University of East Anglia specializing in double-blind trials, oncology, and metabolic alterations in cancer.

Publications per year

2011–2011

1

Publications

1

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer:

Andrew J.S. Coats, Venkatesan Srinivasan, J Surendran et al. · Journal of Cachexia Sarcopenia and Muscle · 2011 · 59 citations · Full text

, , +15

1–1 of 1